The decreased numbers of CD8+ and GZMB+ cells were observed in OG‐L002‐treated and NC group in Model 2 compared to those in Model 1, indicating that the recurrent xenografts exhibited the impaired effector T cell ability in TME compared with the original tumour (Figures 4G, 5G and Figure S4). The gene discussed is CD8A; the disease is neoplasm.